Why the study?
Does the UCP2 45-bp insertion/deletion polymorphism associate with severe obesity or affect weight loss response to dietary changes in morbidly obese subjects?
Does the UCP2 45-bp insertion/deletion polymorphism associate with severe obesity or affect weight loss response to dietary changes in morbidly obese subjects?
The UCP2 ins/del polymorphism is not associated with morbid obesity but may predict a favorable response to dietary weight loss in metabolically healthy obese individuals.
May identify metabolically healthy obese likely to respond to diet; hypothesis-generating and requires prospective validation before genotyping.
BACKGROUND: Uncoupling proteins are attractive candidate genes for obesity and type 2 diabetes mellitus. Our aim was to investigate the potential association of the uncoupling protein-2 (UCP2) 45-bp insertion/deletion (ins/del) polymorphism with obesity, as well as the potential effect of this polymorphism on weight loss variability in severely obese subjects. METHODS: A total of 158 severely obese subjects (94 without and 64 with metabolic syndrome) and 91 age and sex-matched lean controls were recruited. A subgroup of 124 obese patients participated in a 3-month weight loss program. Anthropometric and metabolic variables were measured. Participants were genotyped for the UCP2 ins/del polymorphism. RESULTS: Allelic frequency differed neither between obese subjects and controls (P=0.56), nor between obese subjects with versus without metabolic syndrome (P=0.58). At 3 months, metabolically healthy subjects carrying the insertion allele had significantly greater reduction in body mass index (P=0.029) and fat-free mass (P=0.013) and a borderline significant improvement in the homeostatic model assessment index (P=0.048). CONCLUSION: There is no association of the UCP2 ins/del polymorphism with morbid obesity in our population, but this genotype appears to be linked with a favorable response to dietary changes in metabolically healthy obese subjects.
No takes yet. Share an insight, caveat, or question.
Papazoglou et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: